Results 251 to 260 of about 510,210 (307)

Apigenin Suppresses Bladder Cancer via the SIRT6-NCOA2-PPARα Axis. [PDF]

Int J Biol Sci
Liu Y, Shi ZD, Wei YF, Jiang SY, Patel H, Liu QZ, Dong Y, Liu YF, Hao L, Gao S, Yang DH, Li Q, Han CH.   +12 more
europepmc   +1 more source

Psychological distress among bladder cancer patients: A systematic review. [PDF]

Urol Ann
Indraswari MT, Rahman F, Hamid ARAH, Mochtar CA.   +3 more
europepmc   +1 more source

ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer. [PDF]

Clin Cancer Res
Epstein IB, Odogiyon A, Berg S, Otani Y, Mantia C, Pompa IR, Mossanen M, Wan J, Saraf A, Preston M, Ravi A, Carvalho F, Herberts C, ElNaggar A, Clinton T, Roberts D, Peng L, McGregor B, Bellmunt J, Kamran SC, Berchuck JE, Efstathiou JA, Miyamoto DT, Mouw KW.   +23 more
europepmc   +1 more source

Overview of tumor-resident intratumoral microbiota in human bladder cancer. [PDF]

Transl Androl Urol
Jia B, Rao B, Chen R, Cui K, Cui J, Jin B, Chen S, Wang Z, Duan L, Wang N.   +9 more
europepmc   +1 more source

Comprehensive Analysis Based on the Cancer-Immunity Cycle Identifies a Novel Immunosuppressive Subtype of Bladder Cancer. [PDF]

Int J Genomics
Deng Z, Li Y, Shen Y, Zhou M.
europepmc   +1 more source

Editorial concerning “Pelvic lymph node dissection may be limited on the contralateral side in strictly unilateral bladder cancer without compromising oncological radicality”

Bladder Cancer
doaj   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bladder cancer

Current Opinion in Oncology, 2010
To review the diagnosis and management of all stages of bladder cancer with an emphasis on studies and developments within the last year.Cystoscopy remains the gold standard for diagnosis of bladder tumors, though fluorescent light and urinary biomarkers can both improve the sensitivity of cancer detection.
Todd M, Morgan, Peter E, Clark
openaire   +2 more sources